DACS
EXAS

Dymon Asia Capital (Singapore)’s Exact Sciences EXAS Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,713
Closed -$1.15M – 113
2021
Q1 		$1.15M Buy
+8,713
New +$1.19M 0.08% 85

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s EXAS Position: Q2 2021 in Review

Dymon Asia Capital (Singapore) sold out of Exact Sciences (EXAS) in Q2 2021, closing a stake of 8,713 shares — an estimated $1.15M sold.

Dymon Asia Capital (Singapore) first reported a position in EXAS in Q1 2021 and held it in 1 quarter. The position peaked at $1.15M in Q1 2021. 623 funds tracked by Wall St. Rank hold EXAS as of Q2 2021.

  • Dymon Asia Capital (Singapore) reported no remaining Exact Sciences position as of Q2 2021 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 8,713 Exact Sciences shares in Q2 2021, an estimated $1.15M.
  • Dymon Asia Capital (Singapore) first reported a position in Exact Sciences in Q1 2021 and held it in 1 quarter.
  • Dymon Asia Capital (Singapore)'s Exact Sciences position peaked at $1.15M in Q1 2021.
  • 623 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2021.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2021, filed 13 Aug 2021.